-
When we speak of sudden interruption of treatment, we refer to a period of 1-7 days, while gradual interruption implies the use of a drug at reduced doses for at least 14 days. In order to verify the results obtainable with a sudden to gradual interruption of antidepressants, some Italian researchers have followed 398 patients affected by major depression (224 subjects), panic attacks (75), type I (37) or type II (62) bipolar disorders.
MedNews (Psichiatria) - Lun, 12 Dicembre 2011
http://mn.medsurfnews.com/
-
Newer antidepressants seem to be about as effective as one another, a new analysis indicates. This suggests that the choice of which drug is appropriate for which patient should be made on the basis of such considerations as side effects, cost and patient preference.
Medline Plus (Psichiatria) - Mar, 6 Dicembre 2011
http://www.nlm.nih.gov/medlineplus
-
The provision of long-term mental health care for people with severe mental disorders has been, and still is, one of the major challenges for mental health systems reform in the last decades, for various reasons.
Health-EU (Psichiatria) - Lun, 21 Novembre 2011
http://ec.europa.eu/health-eu/index_en.htm
-
The guide is the latest in its series of good practice guides to support commissioners in designing high quality, evidence-based services to improve outcomes for patients and to help the NHS make better use of its resources. The guide draws on the recent NICE clinical guideline on the identification of and pathways to care for common mental health disordersi, as well as other relevant NICE guidance and quality standards.
National Institute for Health and Clinical Excellence (Psichiatria) - Mer, 2 Novembre 2011
http://www.nice.org.uk
-
The Lancet Series on Global Mental Health 2011 follows up on the pioneering set of papers published by the journal in 2007. It tracks progress over the past four years, and adds information to provide an indispensible resource for health workers and policymakers.
The Lancet (Psichiatria) - Mar, 25 Ottobre 2011
http://www.thelancet.com
-
The U.S. Food and Drug Administration approved the first generic versions of olanzapine to treat schizophrenia and bipolar disorder. Generic drugs approved by FDA have the same high quality, strength, purity, and stability as brand-name drugs. The generic manufacturing, packaging, and testing sites must pass the same quality standards as those of brand name drugs.
Food and Drug Administration (Psichiatria) - Mar, 25 Ottobre 2011
http://www.fda.gov
-
One in four people will require mental health care at some point in their lives but in many countries only two per cent of all health sector resources are invested in mental health services. The report also finds that the bulk of those resources are often spent on services that serve relatively few people.
World Health Organization (Psichiatria) - Mar, 11 Ottobre 2011
http://www.who.int
-
The report, Mental Illness Surveillance Among Adults in the United States, appears as a supplement in today’s issue of the CDC Morbidity and Mortality Weekly Report. Prepared by the Public Health Surveillance Program Office, it is the first agency-wide compilation of data from selected surveillance and information systems that measure the prevalence and effects of mental illness in the U.S. adult population.
Centers for Disease Control and Prevention (CDC) (Psichiatria) - Mar, 6 Settembre 2011
http://www.cdc.gov/
-
Results from a 1601 participants suggest that the BAI may be used as a severity indicator of anxiety in primary care patients with different anxiety disorders. However, because the instrument seems to reflect the severity of depression as well, it is not a suitable instrument to discriminate between anxiety and depression in a primary care population.
BioMed Central (Psichiatria) - Lun, 4 Luglio 2011
http://www.biomedcentral.com
-
This new NICE guideline on the identification of and pathways to care for common mental health disorders focuses on primary care. It draws on existing NICE guidelines and makes new recommendations on how patients are assessed, and when and how they are referred to other services for treatment. The guideline also provides clear advice to managers and commissioners on how to develop referral and care pathways in their local area.
National Institute for Health and Clinical Excellence (Psichiatria) - Lun, 30 Maggio 2011
http://www.nice.org.uk